Difference between revisions of "Part:BBa K563004:Experience"
(→User Reviews) |
|||
Line 19: | Line 19: | ||
<!-- End of the user review template --> | <!-- End of the user review template --> | ||
<!-- DON'T DELETE --><partinfo>BBa_K563004 EndReviews</partinfo> | <!-- DON'T DELETE --><partinfo>BBa_K563004 EndReviews</partinfo> | ||
+ | |||
+ | <!-- DON'T DELETE --> | ||
+ | <partinfo>BBa_K431008 StartReviews</partinfo> | ||
+ | <!-- Template for a user review!--> | ||
+ | {|width='80%' style='border:1px solid gray' | ||
+ | |- | ||
+ | |width='10%'| | ||
+ | <partinfo>BBa_K431008 AddReview 4</partinfo> | ||
+ | <I>UCSF-UCB iGEM 2014</I> | ||
+ | |width='60%' valign='top'| | ||
+ | |||
+ | We used pTEF1 in pSV606 (S. cerevisiae) yeast strains to create a constitutive circuit for our project, and it performed consistently as a constitutive promoter. | ||
+ | We characterized pTEF1 alongside some of its mutants (m3, m6, m7, and m10), as seen in the following graph. If one would like to optimize expressiveness, pTEFm7 was found to have a higher level of constitutiveness than pTEF1, but pTEF1 is still a reliable promoter. | ||
+ | |||
+ | [[File:140630_pTEF1_GFP_ROUND_1.png|800px]] | ||
+ | |||
+ | The mutants were selected from a 2006 paper by Elke Nevoigt and Jessica Kohnke: http://www.ncbi.nlm.nih.gov/pubmed/16885275. | ||
+ | |||
+ | pTEF1 is also listed as parts BBa_K431008 and BBa_K431008. | ||
+ | |||
+ | |}; | ||
+ | <!-- End of the user review template --> |
Revision as of 18:24, 8 October 2014
This experience page is provided so that any user may enter their experience using this part.
Please enter
how you used this part and how it worked out.
Applications of BBa_K563004
User Reviews
UNIQe8bd04b1923b1be7-partinfo-00000000-QINU UNIQe8bd04b1923b1be7-partinfo-00000001-QINU
UNIQe8bd04b1923b1be7-partinfo-00000002-QINU
••••
UCSF-UCB iGEM 2014 |
We used pTEF1 in pSV606 (S. cerevisiae) yeast strains to create a constitutive circuit for our project, and it performed consistently as a constitutive promoter. We characterized pTEF1 alongside some of its mutants (m3, m6, m7, and m10), as seen in the following graph. If one would like to optimize expressiveness, pTEFm7 was found to have a higher level of constitutiveness than pTEF1, but pTEF1 is still a reliable promoter. The mutants were selected from a 2006 paper by Elke Nevoigt and Jessica Kohnke: http://www.ncbi.nlm.nih.gov/pubmed/16885275. pTEF1 is also listed as parts BBa_K431008 and BBa_K431008. |